Laboratorios Farmacéuticos Rovi SA (LABFF)
Market Closed
7 Aug, 20:00
$
67. 17
0
0%
$
4.63B Market Cap
- P/E Ratio
4.37% Div Yield
100 Volume
- Eps
$ 67.17
Previous Close Want to track LABFF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Laboratorios Farmacéuticos Rovi SA (LABFF) Statistics
Valuation metrics
Market Cap 4.63B
Enterprise value 2.96B
Trailing P/E (ttm) 16.12
Forward P/E -
PEG ratio -2.41
Price/Sales (ttm) 3.86
Price/Book (mrq) 4.26
Enterprise Value/Revenue 3.84
Enterprise Value/EBITDA 11.14
Overview
Shares outstanding 51.15M
Float -
Shares short -
% Held by insiders 0.68%
% Held by institutions 0.2%
Average volume (10 days) 17
Average volume (90 days) 28
Price summary
52-Week low 67.17
52-Week high 90.61
Beta -
50-Day moving average 87.77
200-Day moving average 89.94
Dividends and splits
Forward annual dividend rate 4.37
Forward annual dividend yield 0.0482%
Trailing annual dividend rate 0.78
Trailing annual dividend yield 0.0133%
5-Year annual dividend yield -
Payout ratio 0.26
Dividend Date 15 Jul 2026
Ex-Dividend Date 13 Jul 2026
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.24%
Operating margin 0.22%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.28%
Income Statement
Revenue (ttm) 763.75M
Revenue per share (ttm) 15.11
Quarterly revenue growth (yoy) -
Gross profit (ttm) 478.35M
EBITDA 207.61M
Net income to common (ttm) 136.88M
Diluted EPS (ttm) 3.62
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.5
Total debt (mrq) 123.62M
Total Debt/Equity (mrq) 0.15
Current ratio (mrq) 2.05%
Book value per share (mrq) 14.02
Cash Flow
Cash flow statement 203.9M
Levered free cash flow (LFCF) 136.88M
